Dr Jessica Cale is a Research Fellow with the Molecular Therapy Laboratory at the Personalised Medicine Centre, a joint venture between Murdoch University and the Perron Institute. Jessica completed her PhD at Murdoch University in 2021 under the supervision of Professor Steve Wilton AO and Professor Sue Fletcher AO, specialising in antisense therapies for Malan syndrome, a rare connective tissue disorder. Since 2021, Jessica has been involved in commercial-in-confidence, industry-funded research contracts with Senisca Ltd. (UK) and Lyramid Ltd. (Australia), where her work on antisense oligonucleotide therapies for healthy aging and cancer resulted in being named as an inventor on an international patent application. Jessica continues to work on industry-funded projects, acting as senior postdoctoral scientist on a multi-year research program funded by industry partner, Sarepta Therapeutics (US). She also undertakes grant-funded research, leveraging her seven years of experience in therapeutic design for rare and global health disorders.

View Publications   Email